Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
The American Journal of Pathology|June 13, 2025
The Link Between Alcohol Consumption and Kidney InjuryBurhan Yokus, Luca Maccioni, Lihong Fu, et al.Cellular and Molecular Gastroenterology and Hepatology|May 2, 2024
Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic TargetsDechun Feng, Seonghwan Hwang, Adrien Guillot, et al.Ebiomedicine|May 1, 2022
Liver alterations are not improved by inulin supplementation in alcohol use disorder patients during alcohol withdrawal: A pilot randomized, double-blind, placebo-controlled studyCamille Amadieu, Luca Maccioni, Sophie Leclercq, et al.Hepatology Communications|April 14, 2023
Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humansLuca Maccioni, Joyce Kasavuli, Sophie Leclercq, et al.Metabolites|May 28, 2022
Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use DisorderBei Gao, Suling Zeng, Luca Maccioni, et al.Alimentary Pharmacology & Therapeutics|August 3, 2022
Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol-associated liver disease in humansLuca Maccioni, Axelle Loriot, Joseph Dewulf, et al.Gut Microbes|June 27, 2020
Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humansLuca Maccioni, Bei Gao, Sophie Leclercq, et al.Journal of Medicinal Chemistry|October 11, 2025
Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic DisordersPinaki Bhattacharjee, Szabolcs Dvorácskó, Paul Volesky, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2025
Serum Metabolite Profile in Progressive Versus Nonprogressive Alcohol-Related Liver Disease: A Cross-Sectional Metabolomics StudyEemeli Puhakka, Hany Ahmed, Retu Haikonen, et al.Hepatology Communications|July 24, 2019
Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and FibrosisPeter Stärkel, Bernd Schnabl, Sophie Leclercq, et al.Pageof 3